| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00432-016-2222-4 |
| P698 | PubMed publication ID | 27562865 |
| P50 | author | Kati Erdmann | Q88206176 |
| P2093 | author name string | Manfred P Wirth | |
| Susanne Fuessel | |||
| Knut Kaulke | |||
| Karsten Salomo | |||
| Christiane Rieger | |||
| P2860 | cites work | MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 |
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| miRecords: an integrated resource for microRNA-target interactions | Q24655642 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Oncogenic MicroRNAs: Key Players in Malignant Transformation | Q26773316 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells | Q28263458 | ||
| microRNA involvement in human cancer | Q28264087 | ||
| MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis | Q28269041 | ||
| Targeting cell cycle regulation in cancer therapy | Q28284405 | ||
| MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
| Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
| MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
| MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells | Q28551027 | ||
| The polycomb group protein EZH2 is involved in progression of prostate cancer | Q29614514 | ||
| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent | Q30538848 | ||
| Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data | Q30872480 | ||
| EZH2: not EZHY (easy) to deal. | Q33610902 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines | Q33766326 | ||
| Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression | Q34000446 | ||
| MiR-138 inhibits EZH2 methyltransferase expression and methylation of histone H3 at lysine 27, and affects thermotolerance acquisition. | Q34149228 | ||
| MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines | Q34201826 | ||
| MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma | Q34256676 | ||
| MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene | Q34284590 | ||
| BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia | Q34315303 | ||
| Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. | Q34561758 | ||
| Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis | Q34590225 | ||
| Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro | Q35010133 | ||
| The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival | Q35014682 | ||
| Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. | Q35025741 | ||
| Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs | Q35092050 | ||
| Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms | Q35640345 | ||
| High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer | Q36070061 | ||
| MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. | Q36433424 | ||
| miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression | Q36841322 | ||
| miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis. | Q36917611 | ||
| MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. | Q37046835 | ||
| Roles of the EZH2 histone methyltransferase in cancer epigenetics | Q37250591 | ||
| The end of the road for prostate specific antigen testing? | Q38131353 | ||
| Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. | Q38736898 | ||
| MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3. | Q38850375 | ||
| Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanisms | Q38956261 | ||
| MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer | Q38968175 | ||
| Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients | Q39031668 | ||
| Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme | Q39147552 | ||
| MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer | Q39205978 | ||
| MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. | Q39299200 | ||
| MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta | Q39703169 | ||
| EZH2 promotes proliferation and invasiveness of prostate cancer cells | Q40179181 | ||
| Quantitative multi-gene expression profiling of primary prostate cancer | Q40241443 | ||
| The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer | Q40297700 | ||
| MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma | Q46557240 | ||
| MicroRNA-26a modulates transforming growth factor beta-1-induced proliferation in human fetal lung fibroblasts. | Q51679510 | ||
| Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. | Q52887077 | ||
| Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma. | Q54183288 | ||
| MiR-26a inhibits prostate cancer progression by repression of Wnt5a. | Q54200488 | ||
| P433 | issue | 11 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2249-2261 | |
| P577 | publication date | 2016-08-25 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells | |
| P478 | volume | 142 |
| Q49262019 | An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment. |
| Q55361958 | Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model. |
| Q41721802 | Discovering the miR-26a-5p Targetome in Prostate Cancer Cells |
| Q33914244 | Functional and therapeutic significance of EZH2 in urological cancers |
| Q89553356 | Human Mesenchymal Stem Cells-mediated Transcriptomic Regulation of Leukemic Cells in Delivering Anti-tumorigenic Effects |
| Q48031592 | Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells. |
| Q58781915 | MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer |
| Q90249243 | Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2 |
| Q91726582 | Pivotal role of microRNA-138 in human cancers |
| Q46537204 | Prostate cancer health disparities: An immuno-biological perspective |
| Q92838715 | miR-138-5p acts as a tumor suppressor by targeting hTERT in human colorectal cancer |
Search more.